Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Droglican® - Chondroitin Sulfate / Glucosamine Hydrochloride
Bioiberica Spain flag Spain
Abstract ID:
Chondroitin Sulfate / Glucosamine Hydrochloride...
Contact Monica Gomez Navarro
Participants
You
Email me a copy of this message
MECHANISM OF ACTION
Chondroitin sulphate and glucosamine in combination promote the development of new cartilage by stimulating the synthesis of both collagen and proteoglycans, this effect is synergic when both drugs ar

Droglican® is the first association chondroitin-glucosamine to be authorized as drug.


Indicated for the symptomatic treatment of osteoarthritis of the knee in patients suffering from moderate to severe pain due to osteoarthritis.


Authorized and commercialized in Spain.


Available for outlicensing.


 

FEATURED
Last Updated Sep 2016
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FDA APPROVED / FINISHED PRODUCT
CORPORATION